Indoleamine 2,3-dioxygenase is a novel prognostic indicator for endometrial cancer.
Ino K, Yoshida N, Kajiyama H, Shibata K, Yamamoto E, Kidokoro K, Takahashi N, Terauchi M, Nawa A, Nomura S, Nagasaka T, Takikawa O, Kikkawa F.
Ino K, et al. Among authors: nawa a.
Br J Cancer. 2006 Dec 4;95(11):1555-61. doi: 10.1038/sj.bjc.6603477. Epub 2006 Nov 21.
Br J Cancer. 2006.
PMID: 17117179
Free PMC article.